Marlo Blazer
Impact in
- Hematology top 5%
- Multiple Myeloma Research and Treatments
- Acute Myeloid Leukemia Research
- Oncology top 10%
- Pancreatic and Hepatic Oncology Research
- Peptidase Inhibition and Analysis
Papers in
- Oncology 19
- Colorectal Cancer Treatments and Studies 6
- Cancer Treatment and Pharmacology 6
- Pancreatic and Hepatic Oncology Research 6
- Hematology 16
- Multiple Myeloma Research and Treatments 10
- Acute Myeloid Leukemia Research 5
- Co-authors
- Tanios Bekaii‐Saab (9 shared papers)Eileen Farrelly (15 shared papers)Joshua Reardon (5 shared papers)Dorothy Romanus (10 shared papers)Aditya Raju (11 shared papers)Carl Schmidt (3 shared papers)Christina Wu (4 shared papers)Gary Phillips (5 shared papers)
- Journals
- Journal of Clinical Oncology (3 papers)Clinical Colorectal Cancer (2 papers)Leukemia Research (2 papers)Journal of Oncology Practice (2 papers)Blood (2 papers)
- Partner nations
- United StatesUnited KingdomGreece
In The Last Decade
Marlo Blazer
29 papers receiving 557 citations
Peers
Comparison fields: 5 of 51
- Hematology 211
- Oncology 386
- Cancer Research 118
- Genetics 53
- Pulmonary and Respiratory Medicine 131
Countries citing papers authored by Marlo Blazer
This map shows the geographic impact of Marlo Blazer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marlo Blazer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marlo Blazer more than expected).
Fields of papers citing papers by Marlo Blazer
This network shows the impact of papers produced by Marlo Blazer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marlo Blazer. The network helps show where Marlo Blazer may publish in the future.
Co-authors
The 25 scholars most cited alongside Marlo Blazer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 180 | |
| 2 | 2019 | 69 | |
| 3 | 2016 | 41 | |
| 4 | 2018 | 30 | |
| 5 | 2020 | 30 | |
| 6 | 2017 | 28 | |
| 7 | 2018 | 25 | |
| 8 | 2012 | 23 | |
| 9 | 2013 | 19 | |
| 10 | 2015 | 17 | |
| 11 | 2018 | 14 | |
| 12 | 2014 | 12 | |
| 13 | 2019 | 12 | |
| 14 | Realized and Projected Cost-Savings from the Introduction of Generic Imatinib Through Formulary Management in Patients with Chronic Myelogenous Leukemia. | 2019 | 10 |
| 15 | 2015 | 9 | |
| 16 | 2018 | 7 | |
| 17 | 2017 | 6 | |
| 18 | 2015 | 6 | |
| 19 | 2018 | 6 | |
| 20 | 2013 | 5 |
About Marlo Blazer
Marlo Blazer is a scholar working on Oncology, Hematology, Molecular Biology, Genetics and Surgery, having authored 30 papers that have together received 567 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (10 papers), Protein Degradation and Inhibitors (8 papers), Colorectal Cancer Treatments and Studies (6 papers), Cancer Treatment and Pharmacology (6 papers), Pancreatic and Hepatic Oncology Research (6 papers), Acute Myeloid Leukemia Research (5 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (4 papers) and Economic and Financial Impacts of Cancer (3 papers). The work is most often cited by research in Hematology (211 citations), Oncology (386 citations), Cancer Research (118 citations), Genetics (53 citations) and Pulmonary and Respiratory Medicine (131 citations). Marlo Blazer has collaborated with scholars based in United States, United Kingdom and Greece. Frequent co-authors include Tanios Bekaii‐Saab, Eileen Farrelly, Joshua Reardon, Dorothy Romanus, Aditya Raju, Carl Schmidt, Christina Wu, Gary Phillips, Richard M. Goldberg and Peter Muscarella. Their work appears in journals such as Journal of Clinical Oncology, Clinical Colorectal Cancer, Leukemia Research, Journal of Oncology Practice and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.